31 commercial payer policies list J1746. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
31 policies from 16 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J1746 |
|---|---|---|
| Ibalizumab-uiyk (Trogarzo) | Jun 1, 2022 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Ibalizumab-uiyk (Trogarzo) | Nov 1, 2021 | Prior auth requiredInferred from policy title |
| Ibalizumab-uiyk (Trogarzo) | Jun 1, 2023 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Ibalizumab-uiyk (Trogarzo) | Dec 1, 2020 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Ibalizumab-uiyk (Trogarzo) | Feb 1, 2020 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Ibalizumab-uiyk (Trogarzo) | Aug 1, 2018 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Trogarzo (ibalizumab-uiyk injection) | May 1, 2025 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Trogarzo (ibalizumab-uiyk injection) | Not recorded | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Trogarzo (ibalizumab-uiyk injection) | May 1, 2024 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Policy | Effective | Status of J1746 |
|---|---|---|
| Trogarzo (Ibalizumab-Uiyk) | Jun 1, 2026 | Covered |
| Trogarzo (Ibalizumab-Uiyk) – Commercial and Individual Exchange Medical Benefit Drug Policy | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Trogarzo (Ibalizumab-Uiyk) – Community Plan Medical Benefit Drug Policy | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1746 |
|---|---|---|
| Ibalizumab-uiyk | Apr 1, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J1746 |
|---|---|---|
| Ibalizumab-uiyk | Apr 1, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J1746 |
|---|---|---|
| Ibalizumab-uiyk | Apr 1, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J1746 |
|---|---|---|
| Ibalizumab-uiyk | Apr 1, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J1746 |
|---|---|---|
| Ibalizumab-uiyk (Trogarzo) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Ibalizumab-uiyk (Trogarzo) – Minnesota Health Care Programs | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1746 |
|---|---|---|
| TROGARZO | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1746 |
|---|---|---|
| TROGARZO (IBALIZUMAB-ULYK) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1746 |
|---|---|---|
| Ibalizumab Uiyk Trogarzo | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1746 |
|---|---|---|
| Ibalizumab-uiyk (Trogarzo) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1746 |
|---|---|---|
| Ibalizumab-uiyk (Trogarzo); CP. PHAR.378 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1746 |
|---|---|---|
| Ibalizumab-uiyk (Trogarzo) | Aug 21, 2020 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1746 |
|---|---|---|
| Trogarzo (ibalizumab-uiyk) Listed in Moda Health's provider indexes for Oregon, Alaska, Idaho, Texas. The document does not establish the member's state or line of business. | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J1746 |
|---|---|---|
| Trogarzo (Ibalizumab-Uiyk) | Jun 1, 2026 | Covered |
| Policy | Effective | Status of J1746 |
|---|---|---|
| Trogarzo (Ibalizumab-Uiyk) | Jun 1, 2026 | Covered |